Search Results - "Loumaye, E"

Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials by Griesinger, G, Blockeel, C, Pierzynski, P, Tournaye, , H, Višňová, H, Humberstone, A, Terrill, P, Pohl, O, Garner, E, Donnez, J, Loumaye, E

“…Abstract STUDY QUESTION Does a single oral dose of nolasiban 900 mg administered 4 h before embryo transfer (ET) increase pregnancy rates in women undergoing…”
Get full text

GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study by Pirard, C., Donnez, J., Loumaye, E.

“…BACKGROUND: The aim of the study was to investigate whether intranasal (IN) administration of a GnRH agonist could provide luteal support in IVF/ICSI patients…”
Get full text

Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model by Colette, S., Defrère, S., Lousse, J.C., Van Langendonckt, A., Gotteland, J.P., Loumaye, E., Donnez, J.

“…BACKGROUND Steroid sulfatase (STS) is involved in estrogen biosynthesis and expressed in eutopic and ectopic endometrium of disease-free and endometriosis…”
Get full text

GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin by Pirard, C., Donnez, J., Loumaye, E.

“…BACKGROUND: The study objective was to investigate whether repeated intranasal administration of a GnRH agonist could provide convenient and safe luteal…”
Get full text

Absence of aromatase protein and mRNA expression in endometriosis by Colette, S., Lousse, J.C., Defrère, S., Curaba, M., Heilier, J.F., Van Langendonckt, A., Mestdagt, M., Foidart, J.M., Loumaye, E., Donnez, J.

“…BACKGROUND Aromatase has been reported to be involved in estrogen biosynthesis and expressed in eutopic and ectopic endometrium of endometriosis patients. The…”
Get full text

Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation by Loumaye, Ernest, Engrand, Patrick, Shoham, Zeev, Hillier, Stephen G., Baird, David T.

“…BACKGROUND: The objective of these studies was to test the hypothesis that over‐dosing with recombinant human LH (rLH) during the late follicular phase would…”
Get full text

Reply: LH/HCG as a monthly injectable contraceptive by Loumaye, Ernest

Get full text

Inhibition of Steroid Sulfatase Decreases Endometriosis in an In Vivo Murine Model by Colette, S, Defrère, S, Lousse, J. C, Langendonckt, A. Van, Gotteland, J. P, Loumaye, E, Donnez, J

“…Endometriosis is an estrogen-dependent disorder. Treatment with hormonal therapy suppresses estrogen and leads to regression of lesions. However, hormonal…”
Get full text

Living in a hot redox soup: antioxidant defences of the hydrothermal worm Alvinella pompejana by B Genard, B Marie, E Loumaye, B Knoops, P Legendre, F Zal, JF Rees

“…The hydrothermal Pompeii worm Alvinella pompejana lives very close to the walls of black smokers and is therefore exposed to high-temperature venting fluid…”
Get full text

Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment—recombinant HCG versus urinary HCG by The European Recombinant Human Chorionic Gonadotrophin Study Group

“…This multicentre, double-blind, double-dummy, randomized, parallel-group study compared the efficacy and safety of recombinant human chorionic gonadotrophin…”
Get full text

Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility

“…Genes encoding the common gonadotrophin α subunit and follicle stimulating hormone (FSH)-specific β subunit were isolated from a DNA library derived from human…”
Get full text

Clinical evidence for an LH ceiling? by Loumaye, Ernest, Engrand, P., Shoham, Z., Hillier, S.G., Baird, D.T.

Get full text

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? by Howles, C.M., Loumaye, E., Germond, M., Yates, R., Brinsden, P., Healy, D., Bonaventura, L.M., Strowitzki, T.

“…Treatment with growth hormone-releasing factor (GRF) has been reported to improve the ovarian response to gonadotrophins in women who respond poorly to ovarian…”
Get full text

Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study by Howles, C M, Loumaye, E, Giroud, D, Luyet, G

“…A multicentre, multinational study was carried out between November 1990 and February 1992 to assess the safety and efficacy of a new highly purified urinary…”
Get more information

The luteinizing hormone surge--the final stage in ovulation induction: modern aspects of ovulation triggering by Shoham, Z, Schacter, M, Loumaye, E, Weissman, A, MacNamee, M, Insler, V

“…To compile updated information regarding gonadotropin secretion, specifically the physiology of the midcycle LH surge, in natural cycles and under various…”
Get more information

Successful induction of ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome by Kousta, E., White, D.M., Piazzi, A., Loumaye, E., Franks, S.

“…Abstract The induction of ovulation in women with hypogonado-trophic hypogonadism requires follicle stimulating hormone (FSH) for follicular growth and both…”
Get full text

Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration by Porchet, H C, le Cotonnec, J Y, Loumaye, E

“…To investigate the respective role of the pharmacokinetic and of the pharmacodynamic characteristics in individual variability and to reassess the time course…”
Get more information

A placebo-controlled, randomized, double-blind, phase 3 study assessing ongoing pregnancy rates after single oral administration of a novel oxytocin receptor antagonist, nolasiban, prior to single embryo transfer by Visnova, H., Tournaye, H.J., Humberstone, A., Terrill, P., Macgregor, L., Loumaye, E.

Get full text

Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation by Weissman, A., Loumaye, E., Shoham, Z.

“…Three women with hypogonadotrophic hypogonadism, all desiring pregnancy, participated in a prospective open study attempting to assess the ability of the human…”
Get full text

Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test by Loumaye, E, Billion, J M, Mine, J M, Psalti, I, Pensis, M, Thomas, K

“…A clomiphene citrate (CC) challenge test was carried out in 114 patients to evaluate the capacity of this test to predict the patient's individual response to…”
Get more information